Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men

November 2019 in “ Current Geriatrics Reports ”

Eric Bortnick, Vannita Simma‐Chiang, Olamide Omidele, Steven A. Kaplan

finasteride dutasteride tamsulosin benign prostatic hyperplasia BPH tadalafil Propecia Avodart Flomax Cialis

From the encyclopedia

Finasteride →

Frontline, gold standard treatment for combatting androgenic alopecia

Dutasteride →

Heavy duty finasteride that comes with higher risks

tamsulosin →

Studysummary Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The document reviewed medical therapies for treating benign prostatic hyperplasia (BPH) in elderly men, highlighting special considerations for this demographic. It discussed various medications, including Tamsulosin, which was noted for potential increased risks of dementia in older males. The FORTA classification system evaluated medications like Fesoterodine, Finasteride, and Dutasteride as beneficial for BPH treatment. The document also referenced studies on the efficacy and safety of drugs like tadalafil and combination therapies, emphasizing the importance of tailored treatment approaches for older adults with BPH.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Association of Suicidality and Depression With 5α-Reductase Inhibitors

90 citations , March 2017 in “JAMA Internal Medicine”

In this study, older men using 5α-reductase inhibitors for prostatic enlargement did not show increased risk of suicide, but had elevated risks of self-harm and depression.

research Appropriateness of Oral Drugs for Long-Term Treatment of Lower Urinary Tract Symptoms in Older Persons: Results of a Systematic Literature Review and International Consensus Validation Process (LUTS-FORTA 2014)

111 citations , June 2015 in “Age and Ageing”

This study classified dutasteride, fesoterodine, and finasteride as beneficial for older or frail elderly patients, while suggesting caution or avoidance of α-blockers and antimuscarinics in this group.

research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

1707 citations , December 2003 in “The New England Journal of Medicine”

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.